A Synbiotic with Tumor Necrosis Factor-α Inhibitory Activity Ameliorates Experimental Jejunoileal Mucosal Injury

Despite the recent development of biological modifiers for inflammatory bowel diseases (IBD), there continues to be considerable interest in fermented medicines because of its negligible adverse effects. We previously showed that the synbiotic Gut Working Tablet (GWT) alleviates experimental colitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Ryoki, Noguchi, Takayasu, Mizoguchi, Yoko, Shimoyama, Tadashi, Nakazawa, Teruko, Ikuta, Tohru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971273/
https://www.ncbi.nlm.nih.gov/pubmed/29862296
http://dx.doi.org/10.1155/2018/9184093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971273/
https://www.ncbi.nlm.nih.gov/pubmed/29862296
http://dx.doi.org/10.1155/2018/9184093

Ejemplares similares